Ming-Sound Tsao
ScholarGPS® ID: 94533390309661
Affiliation History
Field
Medicine
Discipline
Pathology
Top Specialties
Cancer | Lung Cancer | Non-small-cell Lung Carcinoma | Thorax | Neoplasm | Epidermal Growth Factor Receptor | Radiation Therapy | Mutation | Biomarker | Radiation | Chemotherapy | Epidermal Growth Factor | Growth Factor | Growth Factor Receptor | Genomics
Metrics Summary
Publication Count
850
Predicted Citations
62,620
Predicted h-index
121
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Rediscovering immunohistochemistry in lung cancer (journal article) Critical Reviews in Oncology/Hematology, volume 200 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 2645-2645 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e20013-e20013 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 12092-12092 (2024). |
Journal of Thoracic Oncology (2024). |
CRISPR Screen of Druggable Targets in Small Cell Lung Cancer Identified ATM Inhibitor (AZD1390) as a Radiosensitizer (journal article) International Journal of Radiation Oncology*Biology*Physics, volume 118, issue 5, pages 1308-1314 (2024). |
Journal of Thoracic Oncology (2024). |
β-catenin mediates growth defects induced by centrosome loss in a subset of APC mutant colorectal cancer independently of p53 (journal article) PLOS ONE, volume 19, issue 2, pages e0295030- (2024). |
Patient-derived organoids for prediction of treatment response in oesophageal adenocarcinoma (journal article) British Journal of Surgery, volume 111, issue 1 (2024). |
Histology and molecular testing (book chapter) In Lung Cancer Elsevier (2024) |
The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing—Patient’s Willingness-to-Pay: A Brief Report (journal article) JTO Clinical and Research Reports, volume 5, issue 1, pages 100615- (2024). |
Molecular testing in lung cancer (book chapter) In Diagnostic Molecular Pathology Elsevier (2024) |
Negative Predictive Value of Pre-diagnostic Plasma ctDNA Testing in Patients With Suspected Lung Cancer (journal article) The Journal of Liquid Biopsy, volume 1 (2023). |
Longitudinal Plasma ctDNA Testing in Resected Early-Stage NSCLC (journal article) The Journal of Liquid Biopsy, volume 1 (2023). |
EP06.03-04 Molecular Alterations in Non-Small Cell Lung Cancer Arising in Emphysematous and Fibrotic Lungs (journal article) Journal of Thoracic Oncology, volume 18, issue 11, pages S483- (2023). |
P2.09-28 Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC) (journal article) Journal of Thoracic Oncology, volume 18, issue 11, pages S343-S344 (2023). |
MA04.06 Epigenomic Drug Effect on Osimertinib-Induced Drug Tolerant Persister in a Lung Cancer Patient-Derived Xenograft Model (journal article) Journal of Thoracic Oncology, volume 18, issue 11, pages S111- (2023). |
1353P Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations (journal article) Annals of Oncology, volume 34 (2023). |
2201P Malignant pleural mesothelioma (MPM)-specific DNA methylation patterns in patients using liquid biopsies (journal article) Annals of Oncology, volume 34 (2023). |
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies (journal article) JTO Clinical and Research Reports, volume 4, issue 10, pages 100562- (2023). |